United Kingdom Veterinary Healthcare Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The UK Veterinary Healthcare Market is segmented by Product (Therapeutics and Diagnostics), Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals), and Geography

Market Snapshot

Study Period:

2018 - 2026

Base Year:


Market Value (2018):

USD 1017.70 million

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The risk of zoonotic diseases and rising adoption of pets are the major factors fueling the UK veterinary healthcare market. In the United Kingdom, there were around 8,650,000 dogs and 7,900,000 cats as per the estimates of the European Pet Food Industry: Facts and Figures 2017 (FEDIAF). Additionally, advanced technology is leading to innovations in the animal healthcare sector. Inter-governmental organizations are focusing on formulating reforms, with respect to production of food. Furthermore, these organizations focusing on maintaining the health of animals, through the process of surveillance and vaccination. The aforementioned factors, along with heavy investments in R&D activities are driving the growth of the market studied. However, the increasing costs of animal testing and veterinary services, lack of infrastructure and funding, and use of counterfeit medicines are restraining the growth of the market studied.

Scope of the Report

As per the scope of this report, the UK veterinary healthcare market is growing, and includes therapeutic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include dogs, cats, and horses, among others, and farm animals include swine, poultry, and ruminants.

By Product
Medical Feed Additives
Other Therapeutics
Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
By Animal Type
Dogs and Cats
Other Animals

Report scope can be customized per your requirements. Click here.

Key Market Trends

The molecular diagnostics segment dominates the UK veterinary healthcare market

Molecular diagnostics refer to a class of tests performed on an animal, which can assess its health, at the molecular level. It identifies specific sequences in genes, DNA, RNA, and proteins. It provides insights into whether the animal has a disease or will have a disease in the future. In the United Kingdom, the presence of an extensive network of veterinary diagnostics labs is expected to drive the overall growth of the market. The veterinary diagnostic labs in the United Kingdom offer various services, such as cat genetics, infectious disease PCR tests, and clostridium estertheticum testing. Furthermore, various major market players are focusing on the technological development of diagnostics. This is expected to drive the overall growth of the market.

To understand key trends, Download Sample Report

Competitive Landscape

The UK veterinary healthcare market has been rapidly evolving since the past few years, where technology concerning biotech, genomics, artificial intelligence, cloud computing, and big data witnessed significant growth, which resulted in competition among large animal health companies and collaborations with technologically advanced startups. Moreover, the industry observed significant mergers and acquisitions in the recent years. Thus, the UK veterinary healthcare is highly competitive.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare

      2. 4.2.2 Increasing Pet Ownership

      3. 4.2.3 Increasing Productivity at the Risk of Emerging Zoonosis

    3. 4.3 Market Restraints

      1. 4.3.1 Use of Counterfeit Medicines

      2. 4.3.2 Increasing Costs of Animal Testing and Veterinary Services

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Therapeutics

        1. Vaccines

        2. Parasiticides

        3. Anti-infectives

        4. Medical Feed Additives

        5. Other Therapeutics

      2. 5.1.2 Diagnostics

        1. Immunodiagnostic Tests

        2. Molecular Diagnostics

        3. Diagnostic Imaging

        4. Clinical Chemistry

        5. Other Diagnostics

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Ruminants

      4. 5.2.4 Swine

      5. 5.2.5 Poultry

      6. 5.2.6 Other Animals


    1. 6.1 Company Profiles

      1. 6.1.1 Bayer healthcare

      2. 6.1.2 Boehringer Ingelheim

      3. 6.1.3 Ceva Animal Health Inc.

      4. 6.1.4 Elanco (Elli lilly and company)

      5. 6.1.5 ECO Animal Health

      6. 6.1.6 MSD Animal Health

      7. 6.1.7 Virbac Corporation

      8. 6.1.8 Vetoquinol UK Limited

      9. 6.1.9 Zoetis animal healthcare

  7. *List Not Exhaustive

** Subject to Availability

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports